In the News
Russo Partners works at the intersection of science, medicine, and media. The stories below reflect the conversations we help shape covering breakthroughs in biopharma, digital health, healthcare, and beyond.
Biotech TV
|
September 15, 2026
HCW 2026: InflaRx designed izicopan from the start with the goal of having a differentiated, best in class profile vs the first marketed C5aR inhibitor. Now more than ever this could be opportune
Founder & CEO Niels Riedemann describes what he believes was lacking in design for the competitor, avacopan, which has been…
For more
PharmaVoice
|
September 15, 2026
Cocrystal Pharma’s new CEO hopes to crack the norovirus code
James Sapirstein is bringing his Big Pharma chops to the clinical-stage company’s efforts to finally deliver an effective treatment for…
For more
BioTech Nation
|
September 8, 2026
A Different Approach to Treating Gout…Dr. James Mackay, Co-Founder, CEO, & President, Crystalys Therapeutics
On this episode of BioTech Nation…Dr. James Mackay joins to talk about the progress Crystalys Therapeutics is making in the…
For more
GEN News
|
August 27, 2026
Aprea Expands Development of WEE1 Inhibitor After Seeing Early Clinical Activity Signs vs. Cancer
Aprea Therapeutics is accelerating enrollment in its ongoing Phase I trial of its targeted cancer therapy APR-1051, one of the…
For more
GEN News
|
August 12, 2026
Next 10 U.S. Biopharma Clusters
For the first time, GEN examines the top regions and top states just below the 10 largest regions for life…
For more
Clarivate
|
August 5, 2026
7 weight loss companies to watch: innovators in GLP-1s and beyond
The market for weight loss treatments is a crowded one, and new entrants are piling in. The latest in our…
For more
Pulse 2.0
|
August 5, 2026
Ratio Therapeutics Raises $70 Million Series C To Advance Radiopharmaceutical Pipeline
Ratio Therapeutics has raised $70 million in Series C funding to advance its targeted radiopharmaceutical pipeline and expand its manufacturing…
For more
San Diego Union Tribune
|
July 28, 2026
His father suffered from gout in silence. Now a San Diego scientist is bringing the cure home
As a child, James Mackay watched his father struggle just to stand up. “You shouldn’t have eaten this or that,”…
For more
The Wall Street Journal
|
July 23, 2026
Biotech Startup Gets $130 Million to Settle ‘Unfinished Business’
James Mackay’s previous effort to provide gout patients with a novel treatment ended in disappointment. Venture capitalists are helping him…
For more
Biopharma Dive
|
July 22, 2026
Crystalys nets $130M more to push gout drug through late-stage tests
Less than a year after landing a big funding round, Crystalys Therapeutics has banked a second one, announcing Wednesday a…
For more
Upcoming Events
Our team is active across the industry year-round. Find us at these upcoming conferences and events.
